Bayer AG NA (0P6S.L)
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases, as well as collaboration with Bicycle Therapeutics to develop bicyclic peptides. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.
Company Info
Highlights
€51.70B
€18.28 - €30.89
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of €10,000 in Bayer AG NA, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Bayer AG NA (0P6S.L) returned 21.84% year-to-date (YTD) and -17.49% over the past 12 months. Over the past 10 years, 0P6S.L returned -13.22% annually, underperforming the S&P 500 benchmark at 10.43%.
0P6S.L
21.84%
13.82%
-4.46%
-17.49%
-14.85%
-13.22%
^GSPC (Benchmark)
-3.70%
13.67%
-5.18%
9.18%
14.14%
10.43%
Monthly Returns
The table below presents the monthly returns of 0P6S.L, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 12.95% | 3.94% | -2.47% | 4.85% | 1.49% | 21.84% | |||||||
| 2024 | -12.00% | -5.05% | 1.21% | -2.31% | 1.43% | -5.52% | 5.19% | 0.06% | 9.62% | -18.61% | -22.43% | -0.16% | -42.42% |
| 2023 | 16.59% | -0.86% | 3.97% | 1.73% | -7.70% | -4.06% | 4.98% | -5.02% | -10.04% | -10.75% | -23.67% | 8.29% | -28.37% |
| 2022 | 14.44% | -4.26% | 20.56% | 1.30% | 9.29% | -14.81% | 0.62% | -8.77% | -7.82% | 10.42% | 4.60% | -11.80% | 7.41% |
| 2021 | 3.65% | 0.78% | 7.00% | 3.81% | -2.95% | -1.81% | -1.57% | -6.69% | -0.21% | 4.02% | -7.97% | 4.47% | 1.36% |
| 2020 | 0.26% | -10.73% | -16.79% | 19.11% | -1.68% | 8.35% | -14.52% | -2.15% | -3.13% | -24.29% | 19.60% | -0.24% | -30.83% |
| 2019 | 8.16% | 7.30% | -18.04% | 7.93% | -10.99% | 15.37% | -3.59% | 14.62% | -3.94% | 7.56% | -1.26% | 6.06% | 26.05% |
| 2018 | 1.51% | -8.72% | -4.61% | 8.16% | 5.52% | -5.88% | 1.01% | -15.66% | -4.81% | -11.41% | -4.72% | -6.22% | -39.06% |
| 2017 | 5.51% | 0.65% | 2.68% | 5.86% | 5.54% | -3.02% | 7.47% | -11.42% | 6.90% | -2.97% | -3.64% | -3.52% | 8.46% |
| 2016 | -10.71% | -6.03% | 6.30% | -1.93% | -13.31% | 5.11% | 7.06% | -0.37% | -8.38% | 2.78% | -2.15% | 10.94% | -13.09% |
| 2015 | 13.40% | 3.12% | 6.34% | -7.49% | 2.98% | -4.52% | 6.97% | -9.53% | -5.80% | 5.33% | 4.85% | -8.39% | 4.32% |
| 2014 | -5.21% | 4.89% | -4.17% | 4.04% | 6.12% | -2.59% | -4.29% | 3.16% | 8.67% | 2.30% | 5.80% | -5.92% | 11.94% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of 0P6S.L is 29, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Bayer AG NA (0P6S.L) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Bayer AG NA provided a 0.47% dividend yield over the last twelve months, with an annual payout of €0.11 per share.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | €0.11 | €0.11 | €2.40 | €2.00 | €2.00 | €2.80 | €2.80 | €2.80 | €2.70 | €2.50 | €2.25 | €2.10 |
Dividend yield | 0.47% | 0.57% | 7.14% | 4.09% | 4.25% | 5.81% | 3.84% | 4.62% | 2.64% | 2.59% | 1.97% | 1.89% |
Monthly Dividends
The table displays the monthly dividend distributions for Bayer AG NA. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | €0.00 | €0.00 | €0.00 | €0.11 | €0.00 | €0.11 | |||||||
| 2024 | €0.00 | €0.00 | €0.00 | €0.11 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.11 |
| 2023 | €0.00 | €0.00 | €0.00 | €0.00 | €2.40 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €2.40 |
| 2022 | €0.00 | €0.00 | €0.00 | €0.00 | €2.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €2.00 |
| 2021 | €0.00 | €0.00 | €0.00 | €2.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €2.00 |
| 2020 | €0.00 | €0.00 | €0.00 | €2.80 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €2.80 |
| 2019 | €0.00 | €0.00 | €0.00 | €2.80 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €2.80 |
| 2018 | €0.00 | €0.00 | €0.00 | €0.00 | €2.80 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €2.80 |
| 2017 | €0.00 | €0.00 | €0.00 | €0.00 | €2.70 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €2.70 |
| 2016 | €0.00 | €0.00 | €0.00 | €0.00 | €2.50 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €2.50 |
| 2015 | €0.00 | €0.00 | €0.00 | €0.00 | €2.25 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €2.25 |
| 2014 | €2.10 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €2.10 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Bayer AG NA. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Bayer AG NA was 82.30%, occurring on Dec 23, 2024. The portfolio has not yet recovered.
The current Bayer AG NA drawdown is 77.85%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -82.3% | Apr 14, 2015 | 2438 | Dec 23, 2024 | — | — | — |
| -81.79% | Jan 29, 2001 | 106 | Mar 13, 2003 | 256 | Mar 23, 2007 | 362 |
| -47.32% | Jan 15, 2008 | 295 | Mar 17, 2009 | 435 | Dec 7, 2010 | 730 |
| -37.26% | May 9, 2011 | 97 | Sep 22, 2011 | 184 | Jul 2, 2012 | 281 |
| -12.78% | Dec 9, 2010 | 65 | Mar 16, 2011 | 29 | Apr 28, 2011 | 94 |
Volatility
Volatility Chart
The current Bayer AG NA volatility is 12.30%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Bayer AG NA over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Bayer AG NA, comparing actual results with analytics estimates. In the past quarter, the company did not meet analyst expectations for EPS, resulting in a surprise of -27.8%.
Valuation
The Valuation section provides an overview of how Bayer AG NA is priced in the market compared to other companies in the Drug Manufacturers - General industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for 0P6S.L relative to other companies in the Drug Manufacturers - General industry. Currently, 0P6S.L has a P/S ratio of 0.0. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for 0P6S.L in comparison with other companies in the Drug Manufacturers - General industry. Currently, 0P6S.L has a P/B value of 0.0. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |